News & Mentions

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

OptimizeRx introduces Micro-Neighborhood Targeting to help life sciences marketers synchronize DTC and HCP campaigns. Learn more about AI-driven marketing at Digital Pharma East 2024.

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

Company results from the second quarter of 2024 will be reported on the call on August 8.

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

OptimizeRx Micro-Neighborhood Targeting enables pharma to maintain scale nationwide, as FL, OR, and TX join the list of states updating privacy laws.

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

In a recent study, OptimizeRx’s AI-guided Dynamic Audience Activation Platform (DAAP) delivered three times the return in half the time of the traditional trigger-based program.

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

Financial results for the health tech leader to be discussed during conference call.

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

Call scheduled for 3/28/24, to review FY2023 preliminary revenue & EBITDA on track

Solutions & Technology

By Industry

Learning and Connecting:

Latest:

About Us:

Data & Compliance